Blackrock Health Sciences Trust (BME) : Litman Gregory Asset Management added new position in Blackrock Health Sciences Trust during the most recent quarter end. The investment management firm now holds 1,610 shares of Blackrock Health Sciences Trust which is valued at $59,200 , the company said in a statement filed on May 11, 2016 with the SEC.Blackrock Health Sciences Trust makes up approximately 0.05% of Litman Gregory Asset Management’s portfolio.
Other Hedge Funds, Including , Financial Architects Inc added BME to its portfolio by purchasing 850 company shares during the most recent quarter which is valued at $31,255. Blackrock Health Sciences Trust makes up approx 0.01% of Financial Architects Inc’s portfolio.Ifp Advisors Inc boosted its stake in BME in the latest quarter, The investment management firm added 350 additional shares and now holds a total of 6,392 shares of Blackrock Health Sciences Trust which is valued at $231,326. Blackrock Health Sciences Trust makes up approx 0.01% of Ifp Advisors Inc’s portfolio.
BlackRock Health Sciences Trust’s (BME) (the Trust) investment objective is to provide total return through a combination of current income current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing under normal market conditions at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield. The Trust invests in sectors such as Pharmaceuticals Biotechnology Health Care Equipment & Supplies. Health Care Providers & Services and Life Sciences Tools & Services. The Fund’s investment advisor is BlackRock Advisors LLC.